Home › News

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook

Image: CNBC

Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates amid continued GLP-1 volume growth globally, sending shares up as much as 6% in early trading.

The company updated its outlook to now see adjusted revenue and operating profit growth between negative 2% and 2% at constant exchange rates. It previously saw full-year sales and operating profits, which it hiked in August, at negative 6% to flat for both metrics.

Sales in the third quarter came in at 79.2 billion Danish kroner ($11.9 billion), up 4% year-on-year at constant exchange rates and ahead of FactSet estimates of 73.6 billion kroner.

Continue reading at CNBC

This page shows only an excerpt. The full story is published by CNBC.

More news View More

Rupiah Bangkit ke Rp18.084 per Dolar AS Pagi Ini

CNN Indonesia · 11m ago

Breaking! IHSG Melesat 3%, Ini Penyebabnya

CNBC Indonesia · 11m ago

Rupiah Dibuka Menguat 0,19% ke Rp18.120 per Dolar AS

CNBC Indonesia · 13m ago

Ujian Ketahanan Industri Nasional di Tengah Gejolak Rupiah

Liputan6 · 15m ago

Ditemukan Pelanggaran, BKN Blokir Data Kepegawaian Pemprov Sulbar

Liputan6 · 20m ago

Breaking! Pembukaan IHSG Naik 2% Lebih, Ini Penyebabnya

CNBC Indonesia · 32m ago

Ujian Ketahanan Industri Nasional di Tengah Gejolak Kurs

Liputan6 · 35m ago

IHSG Berakhir Menguat, Simak 5 Saham Pilihan Hari Ini

CNBC Indonesia · 40m ago